chr14-104711014-CA-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_022489.4(INF2):c.2310+8delA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.59 ( 27179 hom., cov: 0)
Exomes 𝑓: 0.56 ( 234135 hom. )
Consequence
INF2
NM_022489.4 splice_region, intron
NM_022489.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.665
Publications
7 publications found
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease dominant intermediate EInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
- focal segmental glomerulosclerosis 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 14-104711014-CA-C is Benign according to our data. Variant chr14-104711014-CA-C is described in ClinVar as Benign. ClinVar VariationId is 261606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.893 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022489.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INF2 | TSL:5 MANE Select | c.2310+8delA | splice_region intron | N/A | ENSP00000376410.4 | Q27J81-1 | |||
| INF2 | TSL:1 | n.2310+8delA | splice_region intron | N/A | ENSP00000483829.2 | A0A087X118 | |||
| INF2 | c.2406+8delA | splice_region intron | N/A | ENSP00000502644.1 | A0A6Q8PHA2 |
Frequencies
GnomAD3 genomes AF: 0.593 AC: 90046AN: 151950Hom.: 27158 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
90046
AN:
151950
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.607 AC: 148676AN: 244882 AF XY: 0.599 show subpopulations
GnomAD2 exomes
AF:
AC:
148676
AN:
244882
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.562 AC: 819702AN: 1459118Hom.: 234135 Cov.: 0 AF XY: 0.562 AC XY: 407783AN XY: 725784 show subpopulations
GnomAD4 exome
AF:
AC:
819702
AN:
1459118
Hom.:
Cov.:
0
AF XY:
AC XY:
407783
AN XY:
725784
show subpopulations
African (AFR)
AF:
AC:
21382
AN:
33440
American (AMR)
AF:
AC:
30997
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
AC:
14942
AN:
26118
East Asian (EAS)
AF:
AC:
35967
AN:
39616
South Asian (SAS)
AF:
AC:
53065
AN:
86156
European-Finnish (FIN)
AF:
AC:
27515
AN:
52022
Middle Eastern (MID)
AF:
AC:
3392
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
597699
AN:
1111106
Other (OTH)
AF:
AC:
34743
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
18428
36855
55283
73710
92138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17192
34384
51576
68768
85960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.593 AC: 90110AN: 152068Hom.: 27179 Cov.: 0 AF XY: 0.597 AC XY: 44337AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
90110
AN:
152068
Hom.:
Cov.:
0
AF XY:
AC XY:
44337
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
26587
AN:
41458
American (AMR)
AF:
AC:
9989
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1961
AN:
3468
East Asian (EAS)
AF:
AC:
4725
AN:
5168
South Asian (SAS)
AF:
AC:
3018
AN:
4830
European-Finnish (FIN)
AF:
AC:
5687
AN:
10588
Middle Eastern (MID)
AF:
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36168
AN:
67950
Other (OTH)
AF:
AC:
1310
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1878
3757
5635
7514
9392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2705
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
1
Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
Focal segmental glomerulosclerosis (1)
-
-
1
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.